Nanjing Well Pharmaceutical GroupLtd Dividends and Buybacks
Dividend criteria checks 3/6
Nanjing Well Pharmaceutical GroupLtd is a dividend paying company with a current yield of 1.25% that is well covered by earnings.
Key information
1.2%
Dividend yield
0.3%
Buyback Yield
Total Shareholder Yield | 1.5% |
Future Dividend Yield | n/a |
Dividend Growth | -0.4% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.300 |
Payout ratio | 28% |
Recent dividend and buyback updates
Recent updates
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Earnings Are Of Questionable Quality
Aug 26Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Upcoming Dividend Will Be Larger Than Last Year's
Jun 07Little Excitement Around Nanjing Well Pharmaceutical Group Co.,Ltd.'s (SHSE:603351) Earnings
Jun 06Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 603351 has been paying a dividend for less than 10 years.
Growing Dividend: 603351 has only been paying a dividend for 6 years, and since then payments have fallen.
Dividend Yield vs Market
Nanjing Well Pharmaceutical GroupLtd Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (603351) | 1.2% |
Market Bottom 25% (CN) | 0.6% |
Market Top 25% (CN) | 2.2% |
Industry Average (Chemicals) | 1.7% |
Analyst forecast (603351) (up to 3 years) | n/a |
Notable Dividend: 603351's dividend (1.25%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 603351's dividend (1.25%) is low compared to the top 25% of dividend payers in the CN market (2.17%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (27.8%), 603351's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (25%), 603351's dividend payments are well covered by cash flows.